Clinical Trials for MorphoSys

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: MorphoSys

Clinical Trials (2)

NCT06029309
Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma
PHASE1/PHASE2Recruiting
27 participants
Started: May 3, 2024 · Completed: May 1, 2032
1 condition4 sponsors1 location
NCT02005289
Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL
PHASE2Active, not recruiting
41 participants
Started: Jan 17, 2014 · Completed: Dec 15, 2025
12 conditions2 sponsors1 location